Technical Analysis for DNLI - Denali Therapeutics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 20.86 | 5.62% | 1.11 |
DNLI closed up 5.62 percent on Wednesday, May 15, 2024, on 1.24 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: May 31
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 200 DMA | Bullish | 0.00% | |
| New Uptrend | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% |
| Alert | Time |
|---|---|
| Fell Below Upper Bollinger Band | about 21 hours ago |
| 60 Minute Opening Range Breakdown | about 21 hours ago |
| Up 5% | about 24 hours ago |
| Gapped Up (Full) | about 24 hours ago |
| Rose Above Previous Day's High | about 24 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/31/2024
Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Neuroscience Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Degenerative Disease Neurodegeneration Senescence
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Neuroscience Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Degenerative Disease Neurodegeneration Senescence
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 33.31 |
| 52 Week Low | 14.56 |
| Average Volume | 1,129,585 |
| 200-Day Moving Average | 19.99 |
| 50-Day Moving Average | 18.69 |
| 20-Day Moving Average | 17.08 |
| 10-Day Moving Average | 18.37 |
| Average True Range | 1.02 |
| RSI (14) | 68.94 |
| ADX | 26.03 |
| +DI | 41.53 |
| -DI | 15.10 |
| Chandelier Exit (Long, 3 ATRs) | 17.84 |
| Chandelier Exit (Short, 3 ATRs) | 17.63 |
| Upper Bollinger Bands | 20.32 |
| Lower Bollinger Band | 13.84 |
| Percent B (%b) | 1.08 |
| BandWidth | 37.99 |
| MACD Line | 0.43 |
| MACD Signal Line | -0.14 |
| MACD Histogram | 0.5675 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 22.15 | ||||
| Resistance 3 (R3) | 22.02 | 21.47 | 21.94 | ||
| Resistance 2 (R2) | 21.47 | 21.14 | 21.53 | 21.86 | |
| Resistance 1 (R1) | 21.16 | 20.94 | 21.32 | 21.29 | 21.79 |
| Pivot Point | 20.61 | 20.61 | 20.68 | 20.67 | 20.61 |
| Support 1 (S1) | 20.30 | 20.28 | 20.46 | 20.43 | 19.93 |
| Support 2 (S2) | 19.75 | 20.08 | 19.81 | 19.86 | |
| Support 3 (S3) | 19.44 | 19.75 | 19.79 | ||
| Support 4 (S4) | 19.57 |
